Verrica Pharmaceuticals Stock
Price
Target price
€6.16
€6.16
-2.150%
-0.135
-2.150%
€9.25
25.04.24 / Stuttgart Stock Exchange
WKN: A2JPEV / Symbol: VRCA / Name: Verrica Pharmaceuticals / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Verrica Pharmaceuticals Stock
We can see a decrease in the price for Verrica Pharmaceuticals. Compared to yesterday it has lost -€0.135 (-2.150%).
Currently there is a rather positive sentiment for Verrica Pharmaceuticals with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 9 € shows a positive potential of 46.22% compared to the current price of 6.16 € for Verrica Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Verrica Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Verrica Pharmaceuticals in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target raised by analysts at HC Wainwright from $12.00 to $13.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Needham & Company LLC from $10.00 to $8.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
